Baird Medical Investment Holdings Limited (BDMD)
Stock analysis · NASDAQ · Healthcare · Medical - Devices
Baird Medical Investment Holdings Limited (BDMD) is a publicly traded company in the Healthcare sector. Latest price: $0.16. Market cap $5.15M. Trailing PE -0.29. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Baird Medical Investment Holdings Limited
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Valuation
| P/E (TTM) | -0.29× |
|---|---|
| P/S (TTM) | 0.21× |
| P/B | 0.19× |
| PEG | 0.00× |
| P/FCF (TTM) | 1.20× |
| EV / EBITDA | -1.47× |
| EV / Sales | 0.78× |
| Earnings Yield | -242.64% |
| Free Cash Flow Yield | 83.62% |
Fundamentals
| Enterprise Value | $19.08M |
|---|---|
| Revenue (TTM) | $24.49M |
| Net Income (TTM) | -$12.50M |
| Free Cash Flow (TTM) | $5.08M |
| Net Debt | $13.93M |
| Working Capital | $10.18M |
| Gross Margin | 85.63% |
| Operating Margin | -58.52% |
| Net Margin | -65.12% |
| Return on Equity | -48.23% |
| Return on Invested Capital | -26.96% |
Peers
Recent News
- Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology
- Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
- Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology
- Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
Related
Browse more tickers: sitemap